Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00FGO
|
||||
| Former ID |
DAP000791
|
||||
| Drug Name |
Melphalan
|
||||
| Synonyms |
Alkeran; Levofalan; Levofolan; Levopholan; Melfalan; Melfalano; Melphalanum; Alanine Nitrogen Mustard; Phenylalanine mustard; Phenylalanine nitrogen mu stard; Phenylalanine nitrogen mustard; AY3360000; CB 3025; ALKERAN (TN); Alkeran (TN); At-290; CB-3025; L-PAM; L-Phenylalanine mustard; L-Sarcolysin; L-Sarcolysine; L-Sarkolysin; Melfalano [INN-Spanish]; Melphalanum [INN-Latin]; SK-15673; TRANSGENIC MODEL EVALUATION (MELPHALAN); MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)); P-L-Sarcolysin; P-L-sarcolysine; TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN); Melphalan (JP15/USP/INN); Melphalan [USAN:INN:BAN:JAN]; P-Bis(beta-chloroethyl)aminophenylalanine; P-N-Di(chloroethyl)aminophenylalanine; P-N-di(chloroethyl)aminophenylala nine; P-Di-(2-chloroethyl)amino-L-phenylalanine; P-N-Bis(2-chloroethyl)amino-L-phenylalanine; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine; P-N,N-bis(2-chloroethyl)amino-L-phenylalanine; (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid; (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid; 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine; 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine; 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine; 4-(Bis(2-chloroethyl)amino)-L-phenylalanine; 4-[Bis(2-chloroethyl)amino]-L-phenylalanine; 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticancer Agents
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H18Cl2N2O2
|
||||
| InChI |
InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1
|
||||
| InChIKey |
SGDBTWWWUNNDEQ-LBPRGKRZSA-N
|
||||
| CAS Number |
CAS 148-82-3
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9332, 611396, 7847435, 7979898, 8149411, 10303302, 10321915, 11335828, 11361067, 11363291, 11365853, 11368415, 11371727, 11374423, 11376577, 11462039, 11484023, 11487890, 11490500, 11492697, 11494211, 14874007, 14898602, 17389837, 24278538, 26611805, 26680129, 26752787, 46509130, 47588994, 47662283, 47736480, 47959741, 48413968, 48416205, 48423637, 48425272, 49831062, 49855032, 49865835, 50105436, 50989121, 53790153, 56463160, 57288513, 57288721, 57405528, 85789225, 91010646, 92307226
|
||||
| SuperDrug ATC ID |
L01AA03
|
||||
| SuperDrug CAS ID |
cas=000148823
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | ||
| References | |||||
| Ref 538468 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 014691. | ||||
| Ref 542608 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7620). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.